The liquid biopsy market size was valued at USD 4.02 bn in 2020-2024. The market is expected to witness robust growth at a CAGR of 38 % during the forecast period 2020-2024. The market sizing has been built and validated using multiple demand-side and supply-side approaches for a detailed understanding of the liquid biopsy market.
The size of the global liquid biopsy market has been derived by triangulating data from multiple sources and approaches. While arriving at the market size, we have considered data points, such as the size of the parent market and the revenues of key market participants, such as ANGLE Plc, Biocept Inc., Bio-Techne Corp., CIRCULOGENE, F. Hoffmann-La Roche Ltd., Guardant Health Inc., LungLife AI Inc., Myriad Genetics Inc., QIAGEN NV, and SAGA Diagnostics AB.
